Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$14.95 - $24.72 $2.99 Million - $4.94 Million
-200,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$17.8 - $25.35 $3.56 Million - $5.07 Million
200,000 New
200,000 $3.9 Million
Q4 2017

Feb 09, 2018

SELL
$21.23 - $34.09 $3.4 Million - $5.45 Million
-160,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$27.0 - $31.11 $4.32 Million - $4.98 Million
160,000
160,000 $4.32 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.55B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.